Physician profile
Jay Napolitano
NPI 1316527278
$2,560.13
in general payments reported to CMS, 2019-2025
15 companies · $2,055 in 2025
The $2,055 reported for 2025 was more than what 86% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.19 · 2022: $129 · 2024: $334 · 2025: $2,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478 · Travel and Lodging: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.72 |
| Travel and Lodging | $911.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,278.55 | 2025 | Senza, Vyrsa V1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $308.50 | 2024-2025 | Relistor, Aldara |
| Spr Therapeutics, INC | $188.73 | 2024-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $175.93 | 2024-2025 | Xtampza, Belbuca |
| Silk Road Medical, INC. | $129.26 | 2022 | |
| Ibsa Pharma INC. | $99.62 | 2024-2025 | Tirosint, Flector, Licart |
| Nevro Corp. | $86.26 | 2024 | Senza |
| Biotronik Nro, INC. | $59.40 | 2025 | Prospera |
| Abbvie INC. | $50.14 | 2025 | |
| Virtus Pharmaceuticals LLC | $47.32 | 2025 | Levorphanol Tartrate |
| Almatica Pharma LLC | $41.19 | 2021 | |
| Valinor Pharma, LLC | $37.74 | 2025 | Movantik |
| Boston Scientific Corporation | $22.46 | 2025 | Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $17.77 | 2025 | Prolate, Nalocet, Tanlor |
| Pfizer INC. | $17.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Napolitano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.